Ronjon Banerjee, M.D. is a warm, patient-centered psychiatrist who meets individuals
where they are on their mental health journey. Drawing from his extensive experience
as both a psychopharmacologist and therapist, Dr. Banerjee uses evidence-based
treatments and cutting-edge innovations to help patients reduce symptoms and achieve
emotional well-being. His therapeutic approach is grounded in empathy, collaboration,
and clinical precision.
Dr. Banerjee is particularly skilled in interventional psychiatry, with deep expertise in
advanced treatments such as Spravato (esketamine), intravenous ketamine,
transcranial magnetic stimulation (TMS), and electroconvulsive therapy (ECT). He
previously served as Medical Director of the Esketamine/TRD Clinic at Mount Sinai and
was an Assistant Professor in both Psychiatry and Neuroscience at the Icahn School of
Medicine.
An accomplished researcher, Dr. Banerjee has participated in numerous clinical trials
targeting treatment-resistant depression, PTSD, and neuromodulation, contributing to
the development of next-generation psychiatric interventions. His work has been
published in leading journals and presented in academic and clinical forums nationwide.
Patients who work with Dr. Banerjee appreciate his calm presence, scientific rigor, and
unwavering commitment to helping them heal. He is dedicated to delivering the highest
standard of care through personalized treatment plans tailored to each individual’s
needs.
